Pruritus Therapeutics Market Report

Global Pruritus Therapeutics Market Study Report 2022 Historical Trends, Growth, and Forecast to 2028

  • POSTDATE：Jun 07, 2022
  • PAGES：183
  • REPORT CODE：GMM825955
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • Pruritus Therapeutics market report explains the definition, types, applications, major countries, and major players of the Pruritus Therapeutics market. The report mainly contains different types, applications, and regional historical data from 2017-2021 and forecast data from 2022-2028.

    The report contains qualitative and quantitative analysis of the entire industry.

    The influence of COVID-19 has been considered in the report. Coronavirus Impact is included in Chapter 2. In addition, Strategic Analytics to Boost Productivity and Profitability is included in Chapter 3.

    By Player:

    • Sanofi

    • Pfizer

    • Tai Guk Pharmaceutical Company

    • Actavis

    • Trevi Therapeutics

    • Cara Therapeutics

    • Ocera Therapeutics Inc

    • NeRRe Therapeutics

    By Type:

    • Corticosteroids

    • Antihistamines

    • Local Anesthetics

    • Counterirritants

    • Immunosuppressant

    • Calcineurin Inhibitors

    • Other Pruritus Therapeutics

    By End-User:

    • Atopic Dermatitis

    • Allergic Contact Dermatitis

    • Urticaria

    • Others

    By Region:

    North America

    • United States

    • Canada

    • Mexico

    Europe

    • Germany

    • UK

    • Spain

    • France

    • Italy

    • Denmark

    • Finland

    • Norway

    • Sweden

    • Poland

    • Russia

    • Turkey

    Asia-Pacific

    • China

    • Japan

    • India

    • South Korea

    • Pakistan

    • Bangladesh

    • Indonesia

    • Thailand

    • Singapore

    • Malaysia

    • Philippines

    • Vietnam

    • Others

    South America

    • Brazil

    • Colombia

    • Chile

    • Argentina

    • Venezuela

    • Peru

    • Puerto Rico

    • Ecuador

    • Others

    GCC

    • Bahrain

    • Kuwait

    • Oman

    • Qatar

    • Saudi Arabia

    • United Arab Emirates

    Africa

    • Nigeria

    • South Africa

    • Egypt

    • Algeriat

    • Others

    Oceania

    • Australia

    • New Zealand

  • TABLE OF CONTENT

    1. Global Pruritus Therapeutics Executive Summary

    • 1.1 Introduction

    • 1.2 Market Panorama, 2022

    2 Coronavirus Impact

    • 2.1 Pruritus Therapeutics Outlook to 2028- Original Forecasts

    • 2.2 Pruritus Therapeutics Outlook to 2028- COVID-19 Affected Forecasts

    • 2.3 Impact on Industry

    3 Strategic Analytics to Boost Productivity and Profitability

    • 3.1 Potential Market Drivers and Opportunities

    • 3.2 New Challenges and Strategies

    • 3.3 Short Term and Long Term Pruritus Therapeutics Market Trends

    4 Key Inferences

    5 Market Overview

    • 5.1 Current Market Scenario

    • 5.2 Porter's Five Forces Analysis

      • 5.2.1 Bargaining Power of Suppliers

      • 5.2.2 Bargaining Power of Consumers

      • 5.2.3 Threat of New Entrants

      • 5.2.4 Threat of Substitute Product and Services

      • 5.2.5 Competitive Rivalry within the Industry

    6 Global Pruritus Therapeutics Market- Recent Developments

    • 6.1 Pruritus Therapeutics Market News and Developments

    • 6.2 Pruritus Therapeutics Market Deals Landscape

    7 Pruritus Therapeutics Raw Materials and Cost Structure Analysis

    • 7.1 Pruritus Therapeutics Key Raw Materials

    • 7.2 Pruritus Therapeutics Price Trend of Key Raw Materials

    • 7.3 Pruritus Therapeutics Key Suppliers of Raw Materials

    • 7.4 Pruritus Therapeutics Market Concentration Rate of Raw Materials

    • 7.5 Pruritus Therapeutics Cost Structure Analysis

      • 7.5.1 Pruritus Therapeutics Raw Materials Analysis

      • 7.5.2 Pruritus Therapeutics Labor Cost Analysis

      • 7.5.3 Pruritus Therapeutics Manufacturing Expenses Analysis

    8 Global Pruritus Therapeutics Import and Export Analysis (Top 10 Countries)

    • 8.1 Global Pruritus Therapeutics Import by Region (Top 10 Countries) (2017-2028)

    • 8.2 Global Pruritus Therapeutics Export by Region (Top 10 Countries) (2017-2028)

    9 Global Pruritus Therapeutics Market Outlook by Types and Applications to 2022

    • 9.1 Global Pruritus Therapeutics Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Corticosteroids Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Antihistamines Consumption and Growth Rate (2017-2022)

      • 9.1.3 Global Local Anesthetics Consumption and Growth Rate (2017-2022)

      • 9.1.4 Global Counterirritants Consumption and Growth Rate (2017-2022)

      • 9.1.5 Global Immunosuppressant Consumption and Growth Rate (2017-2022)

      • 9.1.6 Global Calcineurin Inhibitors Consumption and Growth Rate (2017-2022)

      • 9.1.7 Global Other Pruritus Therapeutics Consumption and Growth Rate (2017-2022)

    • 9.2 Global Pruritus Therapeutics Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Atopic Dermatitis Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Allergic Contact Dermatitis Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Urticaria Consumption and Growth Rate (2017-2022)

      • 9.2.4 Global Others Consumption and Growth Rate (2017-2022)

    10 Region and Country-wise Pruritus Therapeutics Market Analysis and Outlook till 2022

    • 10.1 Global Pruritus Therapeutics Consumption (2017-2022)

    • 10.2 North America Consumption Analysis

      • 10.2.1 United States Pruritus Therapeutics Consumption (2017-2022)

      • 10.2.2 Canada Pruritus Therapeutics Consumption (2017-2022)

      • 10.2.3 Mexico Pruritus Therapeutics Consumption (2017-2022)

    • 10.3 Europe Consumption Analysis

      • 10.3.1 Germany Pruritus Therapeutics Consumption (2017-2022)

      • 10.3.2 UK Pruritus Therapeutics Consumption (2017-2022)

      • 10.3.3 Spain Pruritus Therapeutics Consumption (2017-2022)

      • 10.3.4 Belgium Pruritus Therapeutics Consumption (2017-2022)

      • 10.3.5 France Pruritus Therapeutics Consumption (2017-2022)

      • 10.3.6 Italy Pruritus Therapeutics Consumption (2017-2022)

      • 10.3.7 Denmark Pruritus Therapeutics Consumption (2017-2022)

      • 10.3.8 Finland Pruritus Therapeutics Consumption (2017-2022)

      • 10.3.9 Norway Pruritus Therapeutics Consumption (2017-2022)

      • 10.3.10 Sweden Pruritus Therapeutics Consumption (2017-2022)

      • 10.3.11 Poland Pruritus Therapeutics Consumption (2017-2022)

      • 10.3.12 Russia Pruritus Therapeutics Consumption (2017-2022)

      • 10.3.13 Turkey Pruritus Therapeutics Consumption (2017-2022)

    • 10.4 APAC Consumption Analysis

      • 10.4.1 China Pruritus Therapeutics Consumption (2017-2022)

      • 10.4.2 Japan Pruritus Therapeutics Consumption (2017-2022)

      • 10.4.3 India Pruritus Therapeutics Consumption (2017-2022)

      • 10.4.4 South Korea Pruritus Therapeutics Consumption (2017-2022)

      • 10.4.5 Pakistan Pruritus Therapeutics Consumption (2017-2022)

      • 10.4.6 Bangladesh Pruritus Therapeutics Consumption (2017-2022)

      • 10.4.7 Indonesia Pruritus Therapeutics Consumption (2017-2022)

      • 10.4.8 Thailand Pruritus Therapeutics Consumption (2017-2022)

      • 10.4.9 Singapore Pruritus Therapeutics Consumption (2017-2022)

      • 10.4.10 Malaysia Pruritus Therapeutics Consumption (2017-2022)

      • 10.4.11 Philippines Pruritus Therapeutics Consumption (2017-2022)

      • 10.4.12 Vietnam Pruritus Therapeutics Consumption (2017-2022)

    • 10.5 South America Consumption Analysis

      • 10.5.1 Brazil Pruritus Therapeutics Consumption (2017-2022)

      • 10.5.2 Colombia Pruritus Therapeutics Consumption (2017-2022)

      • 10.5.3 Chile Pruritus Therapeutics Consumption (2017-2022)

      • 10.5.4 Argentina Pruritus Therapeutics Consumption (2017-2022)

      • 10.5.5 Venezuela Pruritus Therapeutics Consumption (2017-2022)

      • 10.5.6 Peru Pruritus Therapeutics Consumption (2017-2022)

      • 10.5.7 Puerto Rico Pruritus Therapeutics Consumption (2017-2022)

      • 10.5.8 Ecuador Pruritus Therapeutics Consumption (2017-2022)

    • 10.6 GCC Consumption Analysis

      • 10.6.1 Bahrain Pruritus Therapeutics Consumption (2017-2022)

      • 10.6.2 Kuwait Pruritus Therapeutics Consumption (2017-2022)

      • 10.6.3 Oman Pruritus Therapeutics Consumption (2017-2022)

      • 10.6.4 Qatar Pruritus Therapeutics Consumption (2017-2022)

      • 10.6.5 Saudi Arabia Pruritus Therapeutics Consumption (2017-2022)

      • 10.6.6 United Arab Emirates Pruritus Therapeutics Consumption (2017-2022)

    • 10.7 Africa Consumption Analysis

      • 10.7.1 Nigeria Pruritus Therapeutics Consumption (2017-2022)

      • 10.7.2 South Africa Pruritus Therapeutics Consumption (2017-2022)

      • 10.7.3 Egypt Pruritus Therapeutics Consumption (2017-2022)

      • 10.7.4 Algeria Pruritus Therapeutics Consumption (2017-2022)

    • 10.8 Oceania Consumption Analysis

      • 10.8.1 Australia Pruritus Therapeutics Consumption (2017-2022)

      • 10.8.2 New Zealand Pruritus Therapeutics Consumption (2017-2022)

    11 Global Pruritus Therapeutics Competitive Analysis

    • 11.1 Sanofi

      • 11.1.1 Sanofi Company Details

      • 11.1.2 Sanofi Pruritus Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 11.1.3 Sanofi Pruritus Therapeutics Main Business and Markets Served

      • 11.1.4 Sanofi Pruritus Therapeutics Product Portfolio

      • 11.1.5 Recent Research and Development Strategies

    • 11.2 Pfizer

      • 11.2.1 Pfizer Company Details

      • 11.2.2 Pfizer Pruritus Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 11.2.3 Pfizer Pruritus Therapeutics Main Business and Markets Served

      • 11.2.4 Pfizer Pruritus Therapeutics Product Portfolio

      • 11.2.5 Recent Research and Development Strategies

    • 11.3 Tai Guk Pharmaceutical Company

      • 11.3.1 Tai Guk Pharmaceutical Company Company Details

      • 11.3.2 Tai Guk Pharmaceutical Company Pruritus Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 11.3.3 Tai Guk Pharmaceutical Company Pruritus Therapeutics Main Business and Markets Served

      • 11.3.4 Tai Guk Pharmaceutical Company Pruritus Therapeutics Product Portfolio

      • 11.3.5 Recent Research and Development Strategies

    • 11.4 Actavis

      • 11.4.1 Actavis Company Details

      • 11.4.2 Actavis Pruritus Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 11.4.3 Actavis Pruritus Therapeutics Main Business and Markets Served

      • 11.4.4 Actavis Pruritus Therapeutics Product Portfolio

      • 11.4.5 Recent Research and Development Strategies

    • 11.5 Trevi Therapeutics

      • 11.5.1 Trevi Therapeutics Company Details

      • 11.5.2 Trevi Therapeutics Pruritus Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 11.5.3 Trevi Therapeutics Pruritus Therapeutics Main Business and Markets Served

      • 11.5.4 Trevi Therapeutics Pruritus Therapeutics Product Portfolio

      • 11.5.5 Recent Research and Development Strategies

    • 11.6 Cara Therapeutics

      • 11.6.1 Cara Therapeutics Company Details

      • 11.6.2 Cara Therapeutics Pruritus Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 11.6.3 Cara Therapeutics Pruritus Therapeutics Main Business and Markets Served

      • 11.6.4 Cara Therapeutics Pruritus Therapeutics Product Portfolio

      • 11.6.5 Recent Research and Development Strategies

    • 11.7 Ocera Therapeutics Inc

      • 11.7.1 Ocera Therapeutics Inc Company Details

      • 11.7.2 Ocera Therapeutics Inc Pruritus Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 11.7.3 Ocera Therapeutics Inc Pruritus Therapeutics Main Business and Markets Served

      • 11.7.4 Ocera Therapeutics Inc Pruritus Therapeutics Product Portfolio

      • 11.7.5 Recent Research and Development Strategies

    • 11.8 NeRRe Therapeutics

      • 11.8.1 NeRRe Therapeutics Company Details

      • 11.8.2 NeRRe Therapeutics Pruritus Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 11.8.3 NeRRe Therapeutics Pruritus Therapeutics Main Business and Markets Served

      • 11.8.4 NeRRe Therapeutics Pruritus Therapeutics Product Portfolio

      • 11.8.5 Recent Research and Development Strategies

    12 Global Pruritus Therapeutics Market Outlook by Types and Applications to 2028

    • 12.1 Global Pruritus Therapeutics Consumption Forecast and Growth Rate by Type (2022-2028)

      • 12.1.1 Global Corticosteroids Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.2 Global Antihistamines Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.3 Global Local Anesthetics Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.4 Global Counterirritants Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.5 Global Immunosuppressant Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.6 Global Calcineurin Inhibitors Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.7 Global Other Pruritus Therapeutics Consumption Forecast and Growth Rate (2022-2028)

    • 12.2 Global Pruritus Therapeutics Consumption Forecast and Growth Rate by Application (2022-2028)

      • 12.2.1 Global Atopic Dermatitis Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.2 Global Allergic Contact Dermatitis Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.3 Global Urticaria Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.4 Global Others Consumption Forecast and Growth Rate (2022-2028)

    13 Country-wise Pruritus Therapeutics Market Analysis and Outlook to 2028

    • 13.1 Global Pruritus Therapeutics Consumption Forecast (2022-2028)

    • 13.2 North America Consumption Analysis

      • 13.2.1 United States Pruritus Therapeutics Consumption Forecast (2022-2028)

      • 13.2.2 Canada Pruritus Therapeutics Consumption Forecast (2022-2028)

      • 13.2.3 Mexico Pruritus Therapeutics Consumption Forecast (2022-2028)

    • 13.3 Europe Consumption Analysis

      • 13.3.1 Germany Pruritus Therapeutics Consumption Forecast (2022-2028)

      • 13.3.2 UK Pruritus Therapeutics Consumption Forecast (2022-2028)

      • 13.3.3 Spain Pruritus Therapeutics Consumption Forecast (2022-2028)

      • 13.3.4 Belgium Pruritus Therapeutics Consumption Forecast (2022-2028)

      • 13.3.5 France Pruritus Therapeutics Consumption Forecast (2022-2028)

      • 13.3.6 Italy Pruritus Therapeutics Consumption Forecast (2022-2028)

      • 13.3.7 Denmark Pruritus Therapeutics Consumption Forecast (2022-2028)

      • 13.3.8 Finland Pruritus Therapeutics Consumption Forecast (2022-2028)

      • 13.3.9 Norway Pruritus Therapeutics Consumption Forecast (2022-2028)

      • 13.3.10 Sweden Pruritus Therapeutics Consumption Forecast (2022-2028)

      • 13.3.11 Poland Pruritus Therapeutics Consumption Forecast (2022-2028)

      • 13.3.12 Russia Pruritus Therapeutics Consumption Forecast (2022-2028)

      • 13.3.13 Turkey Pruritus Therapeutics Consumption Forecast (2022-2028)

    • 13.4 APAC Consumption Analysis

      • 13.4.1 China Pruritus Therapeutics Consumption Forecast (2022-2028)

      • 13.4.2 Japan Pruritus Therapeutics Consumption Forecast (2022-2028)

      • 13.4.3 India Pruritus Therapeutics Consumption Forecast (2022-2028)

      • 13.4.4 South Korea Pruritus Therapeutics Consumption Forecast (2022-2028)

      • 13.4.5 Pakistan Pruritus Therapeutics Consumption Forecast (2022-2028)

      • 13.4.6 Bangladesh Pruritus Therapeutics Consumption Forecast (2022-2028)

      • 13.4.7 Indonesia Pruritus Therapeutics Consumption Forecast (2022-2028)

      • 13.4.8 Thailand Pruritus Therapeutics Consumption Forecast (2022-2028)

      • 13.4.9 Singapore Pruritus Therapeutics Consumption Forecast (2022-2028)

      • 13.4.10 Malaysia Pruritus Therapeutics Consumption Forecast (2022-2028)

      • 13.4.11 Philippines Pruritus Therapeutics Consumption Forecast (2022-2028)

      • 13.4.12 Vietnam Pruritus Therapeutics Consumption Forecast (2022-2028)

    • 13.5 South America Consumption Analysis

      • 13.5.1 Brazil Pruritus Therapeutics Consumption Forecast (2022-2028)

      • 13.5.2 Colombia Pruritus Therapeutics Consumption Forecast (2022-2028)

      • 13.5.3 Chile Pruritus Therapeutics Consumption Forecast (2022-2028)

      • 13.5.4 Argentina Pruritus Therapeutics Consumption Forecast (2022-2028)

      • 13.5.5 Venezuela Pruritus Therapeutics Consumption Forecast (2022-2028)

      • 13.5.6 Peru Pruritus Therapeutics Consumption Forecast (2022-2028)

      • 13.5.7 Puerto Rico Pruritus Therapeutics Consumption Forecast (2022-2028)

      • 13.5.8 Ecuador Pruritus Therapeutics Consumption Forecast (2022-2028)

    • 13.6 GCC Consumption Analysis

      • 13.6.1 Bahrain Pruritus Therapeutics Consumption Forecast (2022-2028)

      • 13.6.2 Kuwait Pruritus Therapeutics Consumption Forecast (2022-2028)

      • 13.6.3 Oman Pruritus Therapeutics Consumption Forecast (2022-2028)

      • 13.6.4 Qatar Pruritus Therapeutics Consumption Forecast (2022-2028)

      • 13.6.5 Saudi Arabia Pruritus Therapeutics Consumption Forecast (2022-2028)

      • 13.6.6 United Arab Emirates Pruritus Therapeutics Consumption Forecast (2022-2028)

    • 13.7 Africa Consumption Analysis

      • 13.7.1 Nigeria Pruritus Therapeutics Consumption Forecast (2022-2028)

      • 13.7.2 South Africa Pruritus Therapeutics Consumption Forecast (2022-2028)

      • 13.7.3 Egypt Pruritus Therapeutics Consumption Forecast (2022-2028)

      • 13.7.4 Algeria Pruritus Therapeutics Consumption Forecast (2022-2028)

    • 13.8 Oceania Consumption Analysis

      • 13.8.1 Australia Pruritus Therapeutics Consumption Forecast (2022-2028)

      • 13.8.2 New Zealand Pruritus Therapeutics Consumption Forecast (2022-2028)

    14 Conclusions


    The List of Tables and Figures

    • Table Definition of Pruritus Therapeutics

    • Figure of Pruritus Therapeutics Picture

    • Table Global Pruritus Therapeutics Import by Region (Top 10 Countries) (2017-2028)

    • Table Global Pruritus Therapeutics Export by Region (Top 10 Countries) (2017-2028)

    • Figure Global Corticosteroids Consumption and Growth Rate (2017-2022)

    • Figure Global Antihistamines Consumption and Growth Rate (2017-2022)

    • Figure Global Local Anesthetics Consumption and Growth Rate (2017-2022)

    • Figure Global Counterirritants Consumption and Growth Rate (2017-2022)

    • Figure Global Immunosuppressant Consumption and Growth Rate (2017-2022)

    • Figure Global Calcineurin Inhibitors Consumption and Growth Rate (2017-2022)

    • Figure Global Other Pruritus Therapeutics Consumption and Growth Rate (2017-2022)

    • Figure Global Atopic Dermatitis Consumption and Growth Rate (2017-2022)

    • Figure Global Allergic Contact Dermatitis Consumption and Growth Rate (2017-2022)

    • Figure Global Urticaria Consumption and Growth Rate (2017-2022)

    • Figure Global Others Consumption and Growth Rate (2017-2022)

    • Figure Global Pruritus Therapeutics Consumption by Country (2017-2022)

    • Table North America Pruritus Therapeutics Consumption by Country (2017-2022)

    • Figure United States Pruritus Therapeutics Consumption and Growth Rate (2017-2022)

    • Figure Canada Pruritus Therapeutics Consumption and Growth Rate (2017-2022)

    • Figure Mexico Pruritus Therapeutics Consumption and Growth Rate (2017-2022)

    • Table Europe Pruritus Therapeutics Consumption by Country (2017-2022)

    • Figure Germany Pruritus Therapeutics Consumption and Growth Rate (2017-2022)

    • Figure UK Pruritus Therapeutics Consumption and Growth Rate (2017-2022)

    • Figure Spain Pruritus Therapeutics Consumption and Growth Rate (2017-2022)

    • Figure Belgium Pruritus Therapeutics Consumption and Growth Rate (2017-2022)

    • Figure France Pruritus Therapeutics Consumption and Growth Rate (2017-2022)

    • Figure Italy Pruritus Therapeutics Consumption and Growth Rate (2017-2022)

    • Figure Denmark Pruritus Therapeutics Consumption and Growth Rate (2017-2022)

    • Figure Finland Pruritus Therapeutics Consumption and Growth Rate (2017-2022)

    • Figure Norway Pruritus Therapeutics Consumption and Growth Rate (2017-2022)

    • Figure Sweden Pruritus Therapeutics Consumption and Growth Rate (2017-2022)

    • Figure Poland Pruritus Therapeutics Consumption and Growth Rate (2017-2022)

    • Figure Russia Pruritus Therapeutics Consumption and Growth Rate (2017-2022)

    • Figure Turkey Pruritus Therapeutics Consumption and Growth Rate (2017-2022)

    • Table APAC Pruritus Therapeutics Consumption by Country (2017-2022)

    • Figure China Pruritus Therapeutics Consumption and Growth Rate (2017-2022)

    • Figure Japan Pruritus Therapeutics Consumption and Growth Rate (2017-2022)

    • Figure India Pruritus Therapeutics Consumption and Growth Rate (2017-2022)

    • Figure South Korea Pruritus Therapeutics Consumption and Growth Rate (2017-2022)

    • Figure Pakistan Pruritus Therapeutics Consumption and Growth Rate (2017-2022)

    • Figure Bangladesh Pruritus Therapeutics Consumption and Growth Rate (2017-2022)

    • Figure Indonesia Pruritus Therapeutics Consumption and Growth Rate (2017-2022)

    • Figure Thailand Pruritus Therapeutics Consumption and Growth Rate (2017-2022)

    • Figure Singapore Pruritus Therapeutics Consumption and Growth Rate (2017-2022)

    • Figure Malaysia Pruritus Therapeutics Consumption and Growth Rate (2017-2022)

    • Figure Philippines Pruritus Therapeutics Consumption and Growth Rate (2017-2022)

    • Figure Vietnam Pruritus Therapeutics Consumption and Growth Rate (2017-2022)

    • Table South America Pruritus Therapeutics Consumption by Country (2017-2022)

    • Figure Brazil Pruritus Therapeutics Consumption and Growth Rate (2017-2022)

    • Figure Colombia Pruritus Therapeutics Consumption and Growth Rate (2017-2022)

    • Figure Chile Pruritus Therapeutics Consumption and Growth Rate (2017-2022)

    • Figure Argentina Pruritus Therapeutics Consumption and Growth Rate (2017-2022)

    • Figure Venezuela Pruritus Therapeutics Consumption and Growth Rate (2017-2022)

    • Figure Peru Pruritus Therapeutics Consumption and Growth Rate (2017-2022)

    • Figure Puerto Rico Pruritus Therapeutics Consumption and Growth Rate (2017-2022)

    • Figure Ecuador Pruritus Therapeutics Consumption and Growth Rate (2017-2022)

    • Table GCC Pruritus Therapeutics Consumption by Country (2017-2022)

    • Figure Bahrain Pruritus Therapeutics Consumption and Growth Rate (2017-2022)

    • Figure Kuwait Pruritus Therapeutics Consumption and Growth Rate (2017-2022)

    • Figure Oman Pruritus Therapeutics Consumption and Growth Rate (2017-2022)

    • Figure Qatar Pruritus Therapeutics Consumption and Growth Rate (2017-2022)

    • Figure Saudi Arabia Pruritus Therapeutics Consumption and Growth Rate (2017-2022)

    • Figure United Arab Emirates Pruritus Therapeutics Consumption and Growth Rate (2017-2022)

    • Table Africa Pruritus Therapeutics Consumption by Country (2017-2022)

    • Figure Nigeria Pruritus Therapeutics Consumption and Growth Rate (2017-2022)

    • Figure South Africa Pruritus Therapeutics Consumption and Growth Rate (2017-2022)

    • Figure Egypt Pruritus Therapeutics Consumption and Growth Rate (2017-2022)

    • Figure Algeria Pruritus Therapeutics Consumption and Growth Rate (2017-2022)

    • Table Oceania Pruritus Therapeutics Consumption by Country (2017-2022)

    • Figure Australia Pruritus Therapeutics Consumption and Growth Rate (2017-2022)

    • Figure New Zealand Pruritus Therapeutics Consumption and Growth Rate (2017-2022)

    • Table Sanofi Company Details

    • Table Sanofi Pruritus Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Sanofi Pruritus Therapeutics Main Business and Markets Served

    • Table Sanofi Pruritus Therapeutics Product Portfolio

    • Table Pfizer Company Details

    • Table Pfizer Pruritus Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Pfizer Pruritus Therapeutics Main Business and Markets Served

    • Table Pfizer Pruritus Therapeutics Product Portfolio

    • Table Tai Guk Pharmaceutical Company Company Details

    • Table Tai Guk Pharmaceutical Company Pruritus Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Tai Guk Pharmaceutical Company Pruritus Therapeutics Main Business and Markets Served

    • Table Tai Guk Pharmaceutical Company Pruritus Therapeutics Product Portfolio

    • Table Actavis Company Details

    • Table Actavis Pruritus Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Actavis Pruritus Therapeutics Main Business and Markets Served

    • Table Actavis Pruritus Therapeutics Product Portfolio

    • Table Trevi Therapeutics Company Details

    • Table Trevi Therapeutics Pruritus Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Trevi Therapeutics Pruritus Therapeutics Main Business and Markets Served

    • Table Trevi Therapeutics Pruritus Therapeutics Product Portfolio

    • Table Cara Therapeutics Company Details

    • Table Cara Therapeutics Pruritus Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Cara Therapeutics Pruritus Therapeutics Main Business and Markets Served

    • Table Cara Therapeutics Pruritus Therapeutics Product Portfolio

    • Table Ocera Therapeutics Inc Company Details

    • Table Ocera Therapeutics Inc Pruritus Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Ocera Therapeutics Inc Pruritus Therapeutics Main Business and Markets Served

    • Table Ocera Therapeutics Inc Pruritus Therapeutics Product Portfolio

    • Table NeRRe Therapeutics Company Details

    • Table NeRRe Therapeutics Pruritus Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table NeRRe Therapeutics Pruritus Therapeutics Main Business and Markets Served

    • Table NeRRe Therapeutics Pruritus Therapeutics Product Portfolio

    • Figure Global Corticosteroids Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Antihistamines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Local Anesthetics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Counterirritants Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Immunosuppressant Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Calcineurin Inhibitors Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Other Pruritus Therapeutics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Atopic Dermatitis Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Allergic Contact Dermatitis Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Urticaria Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Others Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Pruritus Therapeutics Consumption Forecast by Country (2022-2028)

    • Table North America Pruritus Therapeutics Consumption Forecast by Country (2022-2028)

    • Figure United States Pruritus Therapeutics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Canada Pruritus Therapeutics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Mexico Pruritus Therapeutics Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Pruritus Therapeutics Consumption Forecast by Country (2022-2028)

    • Figure Germany Pruritus Therapeutics Consumption Forecast and Growth Rate (2022-2028)

    • Figure UK Pruritus Therapeutics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Spain Pruritus Therapeutics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Belgium Pruritus Therapeutics Consumption Forecast and Growth Rate (2022-2028)

    • Figure France Pruritus Therapeutics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Italy Pruritus Therapeutics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Denmark Pruritus Therapeutics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Finland Pruritus Therapeutics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Norway Pruritus Therapeutics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Sweden Pruritus Therapeutics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Poland Pruritus Therapeutics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Russia Pruritus Therapeutics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Turkey Pruritus Therapeutics Consumption Forecast and Growth Rate (2022-2028)

    • Table APAC Pruritus Therapeutics Consumption Forecast by Country (2022-2028)

    • Figure China Pruritus Therapeutics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Pruritus Therapeutics Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Pruritus Therapeutics Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Pruritus Therapeutics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Pakistan Pruritus Therapeutics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Bangladesh Pruritus Therapeutics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Indonesia Pruritus Therapeutics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Thailand Pruritus Therapeutics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Singapore Pruritus Therapeutics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Malaysia Pruritus Therapeutics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Philippines Pruritus Therapeutics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Vietnam Pruritus Therapeutics Consumption Forecast and Growth Rate (2022-2028)

    • Table South America Pruritus Therapeutics Consumption Forecast by Country (2022-2028)

    • Figure Brazil Pruritus Therapeutics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Colombia Pruritus Therapeutics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Chile Pruritus Therapeutics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Argentina Pruritus Therapeutics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Venezuela Pruritus Therapeutics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Peru Pruritus Therapeutics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Puerto Rico Pruritus Therapeutics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Ecuador Pruritus Therapeutics Consumption Forecast and Growth Rate (2022-2028)

    • Table GCC Pruritus Therapeutics Consumption Forecast by Country (2022-2028)

    • Figure Bahrain Pruritus Therapeutics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Kuwait Pruritus Therapeutics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Oman Pruritus Therapeutics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Qatar Pruritus Therapeutics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Saudi Arabia Pruritus Therapeutics Consumption Forecast and Growth Rate (2022-2028)

    • Figure United Arab Emirates Pruritus Therapeutics Consumption Forecast and Growth Rate (2022-2028)

    • Table Africa Pruritus Therapeutics Consumption Forecast by Country (2022-2028)

    • Figure Nigeria Pruritus Therapeutics Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Africa Pruritus Therapeutics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Egypt Pruritus Therapeutics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Algeria Pruritus Therapeutics Consumption Forecast and Growth Rate (2022-2028)

    • Table Oceania Pruritus Therapeutics Consumption Forecast by Country (2022-2028)

    • Figure Australia Pruritus Therapeutics Consumption Forecast and Growth Rate (2022-2028)

    • Figure New Zealand Pruritus Therapeutics Consumption Forecast and Growth Rate (2022-2028)

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US